Pfizer Korea SWOT overview

Pfizer Inc. is a multinational pharmaceutical corporation located in the United States. First founded in 1849, Pfizer Inc. produces a wide array of medical products ranging from Lipitor, a blood cholesterol drug, Lyrica, an antifungal pill, to Viagra, a drug that treats erectile dysfunction.

In 1969, Pfizer merged with Chung-ang Pharmaceuticals marking the start of their Korean branch, Pfizer Korea. At the time of the merger, Chung-ang Pharmaceuticals was a newly founded company of 10 years located in Gwangjingu, Seoul. In 1999, Pfizer Korea introduced Viagra into the Korean market. The Viagra market was monopolized by Pfizer Korea until the inevitable patent expiration in 2012. Most of Pfizer Korea’s profits depend heavily on Viagra sales but other products such as Lipitor, and Champix, an anti-smoking pill, are also well-known.

Pfizer Korea puts a great emphasis on corporate social responsibility and showing respect towards humanity. To achieve this goal, Pfizer Korea holds various projects and events such as providing scholarships for financially challenged university students, funding medical research in Korea, and children raised by their grandparents. Pfizer Korea also plays a big role in providing medical and financial aid for worldwide countries suffering from catastrophic natural disasters such as Pakistan in 2005, Haiti in 2010, and Japan in 2011.


답글 남기기

아래 항목을 채우거나 오른쪽 아이콘 중 하나를 클릭하여 로그 인 하세요: 로고

WordPress.com의 계정을 사용하여 댓글을 남깁니다. 로그아웃 /  변경 )

Google+ photo

Google+의 계정을 사용하여 댓글을 남깁니다. 로그아웃 /  변경 )

Twitter 사진

Twitter의 계정을 사용하여 댓글을 남깁니다. 로그아웃 /  변경 )

Facebook 사진

Facebook의 계정을 사용하여 댓글을 남깁니다. 로그아웃 /  변경 )


%s에 연결하는 중